Literature DB >> 19034422

Thrombosis during lepirudin therapy: a case report.

F Wallet, F Bayle, V Leray, J C Richard, G Bourdin, C Guérin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19034422     DOI： 10.1007/s00134-008-1359-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Heparin-induced thrombocytopenia: diagnosis and management.

Authors:  Theodore E Warkentin
Journal:  Circulation       Date:  2004-11-02       Impact factor: 29.690

2.  Lepirudin: is the approved dosing schedule too high?

Authors:  M Hacquard; E de Maistre; T Lecompte
Journal:  J Thromb Haemost       Date:  2005-11       Impact factor: 5.824

3.  Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.

Authors:  N Lubenow; P Eichler; T Lietz; A Greinacher
Journal:  J Thromb Haemost       Date:  2005-11       Impact factor: 5.824

4.  Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.

Authors:  Bernard Tardy; Thomas Lecompte; Françoise Boelhen; Brigitte Tardy-Poncet; Ismaïl Elalamy; Pierre Morange; Yves Gruel; Martine Wolf; Dominique François; Evelyne Racadot; Philippe Camarasa; Marie Thérèse Blouch; Françoise Nguyen; Sylvie Doubine; Fabienne Dutrillaux; Martine Alhenc-Gelas; Isabelle Martin-Toutain; Anne Bauters; Patrick Ffrench; Emmanuel de Maistre; Lélia Grunebaum; Christine Mouton; Marie G Huisse; Michèle Gouault-Heilmann; Veronique Lucke
Journal:  Blood       Date:  2006-05-11       Impact factor: 22.113

Review 5.  Heparin-induced thrombocytopenia in intensive care patients.

Authors:  Kathleen Selleng; Theodore E Warkentin; Andreas Greinacher
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.